Originally published on The Daily Flare.
The United States and China each channel roughly $800 billion a year into research and development. Here is how the world's biggest R&D spenders compare.
Comparing R&D spending by country is one of the most reliable ways to see where the next wave of products, medicines, and manufacturing processes will come from. The standard measure, gross domestic expenditure on research and development (GERD), counts everything a country spends on basic research, applied research, and experimental development across companies, universities, government labs, and non-profits. It is the number behind every claim about one country "investing more in innovation" than another — and the gap between the leaders and everyone else is enormous.
Getting the comparison right takes care. Converted at market exchange rates, R&D spending looks different than in purchasing power parity (PPP) terms, which adjust for what a dollar of research actually buys in each country. PPP is the fairer yardstick for research capacity: scientists, equipment, and lab space cost far less in Beijing or New Delhi than in Boston or Munich. The figures below use PPP-adjusted dollars, the version of the data the OECD and the UNESCO Institute for Statistics favor for cross-country comparisons.
The global R&D spending by country ranking
In absolute terms, the top five R&D performers are the world's largest economies: the United States, China, Japan, Germany, and South Korea, according to the data tool maintained by the UNESCO Institute for Statistics. But the last decade has rewritten the order at the top. China's R&D spending has grown relentlessly — its share of world GERD has roughly doubled since the mid-2000s — and on PPP measures it has pulled essentially level with the United States. Together, the two countries account for more than half of all R&D spending on the planet.
Below them sits a second tier of long-standing research powers: Japan and Germany, each spending well over $100 billion a year, followed by South Korea. The United Kingdom, India, and France round out the top eight, each in the $65–90 billion range. A few surprises deserve attention: Turkey, Brazil, Russia, and Canada each spend more than $30 billion annually in PPP terms, putting them ahead of many wealthier European economies.
| # | Country | R&D spending (USD) | Share of GDP |
|---|---|---|---|
| 1 | China | $785.9 billion | 2.69% |
| 2 | United States | $781.8 billion | 3.45% |
| 3 | Japan | $186.0 billion | 3.62% |
| 4 | South Korea | $136.4 billion | 5.13% |
| 5 | Germany | $132.2 billion | 3.13% |
| 6 | United Kingdom | $86.5 billion | 2.68% |
| 7 | India | $75.7 billion | 0.65% |
| 8 | France | $65.8 billion | 2.18% |
| 9 | Turkey | $43.2 billion | 1.46% |
| 10 | Brazil | $38.4 billion | 1.19% |
| 11 | Russia | $38.1 billion | 0.94% |
| 12 | Canada | $33.2 billion | 1.79% |
Methodology note. Figures come from the OECD Main Science and Technology Indicators, the UNESCO Institute for Statistics GERD series, and the World Bank R&D expenditure indicator, accessed October 2026. Absolute spending is shown in purchasing power parity (PPP) US dollars — current prices, latest available year — which adjust for differences in research costs across countries; nominal market-exchange-rate figures would rank China lower and leave the US clearly first. R&D intensity is gross domestic spending on R&D as a share of GDP, from the OECD's 2024 data release. Year coverage differs by country: intensity figures for the United Kingdom, India, Brazil, and Russia use the latest World Bank observations (2023, 2020, 2023, and 2024 respectively) because OECD 2024 values were unavailable, and those should be treated as estimates. GERD covers total current and capital expenditure on basic research, applied research, and experimental development performed inside a country by business, government, higher education, and private non-profit sectors; it excludes R&D funded domestically but performed abroad.
Intensity leaders: when share of GDP tells another story
Rank countries by the share of GDP devoted to research instead of absolute dollars, and the leaderboard flips. Israel leads the world: the OECD puts its 2024 R&D intensity at 6.76% of GDP, more than twice the OECD average of 2.72%. South Korea follows at 5.13%, and Taiwan — ranked only tenth by absolute spending — commits 4.10% of its GDP, ahead of the United States (3.45%), Japan (3.62%), and Belgium (3.36%).
The European Union averages just 2.13%, and only a handful of its members clear the old 3% target: Austria, Germany, Sweden, Finland, Denmark, and Belgium. The pattern that repeats everywhere is who pays for the research. In the intensity leaders, companies perform the bulk of R&D — Korea's business sector accounts for the overwhelming majority of its 5% intensity, and the same is true of Japan, the US, and Taiwan. Where the public sector has to carry the load alone, intensity stalls.
The contrast between India and Israel shows how much a single metric can hide. India spends $75.7 billion on R&D — seventh in the world — but at 0.65% of GDP its research economy is small relative to its size. Israel spends a fraction of India's dollars yet commits the largest share of its national income to research anywhere. Neither number alone captures a country's real innovation position; together, they sketch it.
That position shows up directly in output measures. The countries at the top of the R&D spending table are the same ones dominating the global patent rankings: China, the United States, Japan, and South Korea take four of the top five spots in both lists. Spending does not guarantee invention, but sustained funding and patent applications move in lockstep across every major economy.
Where the money goes: chips, medicine, and the research workforce
R&D budgets are not abstract. A disproportionate share of the top countries' research and development spending flows into a few strategic industries, and semiconductors sit at the top of that list. It is no coincidence that the biggest R&D spenders — China, the US, South Korea, Japan, and Taiwan — are also the countries that dominate semiconductor manufacturing. Building a leading-edge chip fab costs tens of billions of dollars before a single wafer is processed; the R&D behind the machines inside it has been funded for decades. South Korea's 5.13% intensity, the highest among large economies, is inseparable from the research budgets of its memory-chip giants.
The United States illustrates how the money is split. The National Center for Science and Engineering Statistics reports that R&D performed in the US totaled $937 billion in 2023 in nominal terms, with an estimated rise to $993 billion in 2024 — well above the PPP-adjusted figures used for international comparison. Most of that is performed and funded by companies, but the public side remains substantial: American universities spent over $117 billion on R&D in fiscal year 2024, with the federal government funding more than half of it. That university research is the seed corn for the next generation of companies — and for the patent applications they will eventually file.
China's trajectory is the decade's defining story. Its 2.69% R&D intensity is still below the US level, but the intensity gap is narrowing as fast as the absolute one closed. The European Union, by contrast, has struggled to lift its 2.13% average, and the UK's position below that mark — combined with its Brexit-era exclusion from some EU research funding — is a standing debate in British science policy.
For businesses and policymakers, the ranking carries a practical lesson. R&D spending is a leading indicator: today's research budgets decide which countries own the patents, fabs, and drug pipelines of 2035. The countries investing the most are buying something no tariff or trade deal can replicate — the capacity to invent the next thing first.
Top comments (0)